In a lung cancer model, MCC950 was found to reduce IL-1β secretion, suppress angiogenesis, and inhibit metastasis through NLRP3 pathway inhibition in tumor-associated macrophages (TAMs) [383]. The gene discussed is IL1B; the disease is neoplasm.